Background The diagnostics of primary aldosteronism (PA) are usually carried out in
patients taking antihypertensive medications. We compared haemodynamics between …

Patients with primary aldosteronism (PA) are at increased cardiovascular risk, compared to
patients with essential hypertension (EH). Cardiovascular damage could depend on PA …

Introduction: Hypokalemia in primary aldosteronism (PA) patients correlates with higher
levels of cardiovascular events and altered left ventricular geometry. However, the influence …

A higher risk of cardiovascular events has been reported in patients with primary
aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH) …

Objective This study was designed to investigate whether the excess aldosterone found in
primary aldosteronism (PA) influences left-ventricular systolic function (LVSF), through a …

The worldwide prevalence of primary aldosteronism (PA) among unselected patients with
hypertension is considered to be 10–15%(1, 2). However, there have always been wide …

Objective: A much higher risk of cardiovascular events has been reported in patients with
primary aldosteronism (PA) than in otherwise similar patients with essential hypertension …

Primary aldosteronism (PA) is a common form of arterial hypertension with a high
prevalence of cardiovascular complications. In patients with PA, complex mechanisms may …

Aldosterone-to-renin ratio (ARR) is a screening tool for primary aldosteronism (PA), but the
significance of ARR when the PA criteria are not met remains largely unknown. In this cross …

Background: Previous studies showed higher risk of cardiovascular and cerebrovascular
(CCV) events in primary aldosteronism compared with essential hypertension, but the …